H Sasano Selected Research

H Sasano Research Topics

Disease

35	Neoplasms (Cancer) 03/2019 - 01/2000
21	Breast Neoplasms (Breast Cancer) 06/2017 - 01/2000
16	Carcinoma (Carcinomatosis) 03/2019 - 01/2000
6	Adenoma (Adenomas) 01/2016 - 03/2000
6	Adenocarcinoma 11/2012 - 03/2000
5	Noninfiltrating Intraductal Carcinoma (DCIS) 06/2017 - 03/2000
5	Cushing Syndrome 01/2007 - 08/2000
5	Ductal Carcinoma 05/2005 - 01/2000
5	Endometriosis 06/2001 - 01/2000
4	Esophageal Squamous Cell Carcinoma 03/2019 - 09/2000
4	Hyperaldosteronism (Conn Syndrome) 01/2016 - 02/2000
4	Ovarian Epithelial Carcinoma 01/2005 - 12/2000
4	Endometrial Neoplasms (Endometrial Cancer) 07/2001 - 01/2000
3	Hypertension (High Blood Pressure) 01/2016 - 04/2001
3	Prostatic Neoplasms (Prostate Cancer) 01/2013 - 01/2009
3	Adrenocortical Adenoma (Disease, Conn's) 01/2007 - 08/2000
3	Hyperplasia 02/2005 - 09/2000
3	Ovarian Neoplasms (Ovarian Cancer) 01/2005 - 09/2001
3	Cysts 01/2005 - 06/2000
3	Endometrial Hyperplasia 07/2001 - 01/2000
3	Adrenocortical Carcinoma 08/2000 - 02/2000
2	Inflammation (Inflammations) 04/2014 - 06/2001
2	Thrombosis (Thrombus) 04/2014 - 10/2000
2	Atrophy 09/2013 - 01/2007
2	Atherosclerosis 08/2006 - 12/2001
2	Biliary Atresia 12/2001 - 07/2001
2	Endometrioid Carcinoma 07/2001 - 10/2000
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2001 - 01/2000
2	Ganglioneuroblastoma 01/2001 - 04/2000
2	Pheochromocytoma 01/2001 - 04/2000
2	Neuroblastoma 01/2001 - 04/2000
2	Carcinogenesis 01/2001 - 03/2000
1	Esophageal Neoplasms (Esophageal Cancer) 03/2019
1	Residual Neoplasm 03/2019
1	Lymphatic Metastasis 03/2019
1	Fibrosis (Cirrhosis) 04/2014

Drug/Important Bio-Agent (IBA)

14	Messenger RNA (mRNA)IBA 01/2012 - 02/2000
13	Estrogens (Estrogen)FDA Link 06/2017 - 01/2000
13	Biological ProductsIBA 01/2013 - 03/2000
9	Aromatase (CYP19)IBA 06/2017 - 01/2000
9	EnzymesIBA 01/2007 - 01/2000
9	SteroidsIBA 06/2001 - 01/2000
8	Estrogen ReceptorsIBA 06/2017 - 01/2000
8	Estrogen Receptor alphaIBA 07/2013 - 03/2000
8	AndrogensIBA 01/2013 - 05/2000
7	AldosteroneIBA 01/2016 - 02/2000
6	Hydrocortisone (Cortisol)FDA LinkGeneric 09/2013 - 02/2001
6	Progesterone Receptors (Progesterone Receptor)IBA 07/2013 - 12/2000
5	Estradiol (Delestrogen)FDA LinkGeneric 06/2017 - 01/2000
5	Aromatase InhibitorsIBA 07/2013 - 01/2000
5	Hormones (Hormone)IBA 05/2001 - 02/2000
4	Dehydroepiandrosterone (DHEA)IBA 01/2013 - 12/2000
4	3 (or 17)-beta-hydroxysteroid dehydrogenaseIBA 01/2009 - 02/2000
4	IsoenzymesIBA 09/2001 - 03/2000
3	ReninIBA 01/2016 - 04/2000
3	Trastuzumab (Herceptin)FDA Link 05/2014 - 01/2001
3	dehydroepiandrosterone sulfotransferaseIBA 09/2013 - 04/2001
3	Testosterone (Sustanon)FDA Link 01/2013 - 02/2000
3	Transcription Factors (Transcription Factor)IBA 01/2012 - 01/2001
3	Adrenocorticotropic Hormone (ACTH)FDA Link 02/2011 - 02/2001
3	Proteins (Proteins, Gene)FDA Link 10/2007 - 01/2001
3	Monoclonal AntibodiesIBA 05/2005 - 01/2001
3	Progesterone FDA LinkGeneric 01/2004 - 12/2000
3	Cadherins (E-Cadherin)IBA 12/2001 - 03/2000
3	Keratins (Keratin)IBA 11/2001 - 03/2000
3	RetinoidsIBA 06/2001 - 11/2000
3	Oxidoreductases (Dehydrogenase)IBA 05/2001 - 01/2000
2	LigandsIBA 03/2019 - 01/2012
2	RNA (Ribonucleic Acid)IBA 04/2014 - 01/2001
2	Biomarkers (Surrogate Marker)IBA 11/2013 - 11/2012
2	Capecitabine (Xeloda)FDA Link 11/2013 - 10/2007
2	Androgen Receptors (Androgen Receptor)IBA 01/2013 - 09/2001
2	Carcinoembryonic AntigenIBA 11/2012 - 03/2000
2	ErbB Receptors (EGF Receptor)IBA 11/2012 - 01/2001
2	Dexamethasone (Maxidex)FDA LinkGeneric 02/2011 - 07/2001
2	ParaffinIBA 10/2010 - 09/2003
2	Interleukin-6 (Interleukin 6)IBA 10/2007 - 03/2001
2	Pharmaceutical PreparationsIBA 10/2007 - 03/2001
2	Gonadal Steroid Hormones (Sex Hormones)IBA 08/2006 - 02/2000
2	PPAR gammaIBA 03/2006 - 03/2001
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2005 - 04/2000
2	Surface Antigens (Surface Antigen)IBA 06/2004 - 11/2001
2	AntibodiesIBA 06/2004 - 04/2000
2	alpha Catenin (alpha E-Catenin)IBA 12/2001 - 03/2000
2	beta CateninIBA 12/2001 - 01/2001
2	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 07/2001 - 02/2000
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 06/2001 - 01/2001
2	Retinoid X Receptors (Retinoid X Receptor)IBA 06/2001 - 11/2000
2	CorticosteroneIBA 03/2001 - 02/2001
2	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 01/2001 - 11/2000
2	ProstaglandinsIBA 09/2000 - 08/2000
2	Dinoprostone (PGE2)FDA Link 09/2000 - 01/2000
2	Hydroxysteroid DehydrogenasesIBA 03/2000 - 01/2000
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 03/2019
1	BilirubinIBA 04/2014

Therapy/Procedure

7	Therapeutics 03/2019 - 08/2001
5	Neoadjuvant Therapy 03/2019 - 10/2005
4	Adrenalectomy 02/2011 - 08/2000
1	Drug Therapy (Chemotherapy) 03/2019
1	Chemoradiotherapy 07/2018